Navigation Links
Ferring to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
Date:2/12/2013

SAN FRANCISCO, Feb. 12, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present pivotal Phase 3 efficacy and safety data from its EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 33rd annual meeting of the Society for Maternal-Fetal Medicine (SMFM) in San Francisco, February 11 - 16. These and other research findings formed the basis for Ferring's New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) supporting the use of the controlled release MVI as a treatment option for cervical ripening as part of the labor induction process.

Studies accepted for presentation include

  • An oral presentation on Sat., Feb. 16 (9 a.m. – 9:15 a.m. PST), titled "Efficacy and safety of misoprostol vaginal insert compared with dinoprostone vaginal insert for labor induction" (lead author: Deborah A. Wing , MD, University of California, Irvine); and
  • A poster presentation on Thurs., Feb. 14 (3:30 p.m. – 5:30 p.m. PST), titled "Comparison of misoprostol vaginal insert and dinoprostone vaginal insert: incidence of treatment-emergent adverse events" (lead author: Stacey Ehrenberg-Buchner , MD, University of Michigan Health System).

*The EXPEDITE Study: A Phase 3, double blind, randomized, multicenter study of exogenous prostaglandin comparing the efficacy and safety of the misoprostol vaginal insert (MVI) 200 mcg to the dinoprostone vaginal insert for reducing time to vaginal delivery in pregnant women at term.

For further information, contact:
Leila Boukassi
MSL New York
leila.boukassi@mslgroup.com; 646.500.7735 

About Ferring Pharmaceuticals:
Ferring Pharmaceuticals is a research-driven speciality biopharmaceutical company, active in global markets. The company identifies, develops and markets innovative products in the areas of general and pediatric endocrinology, gastroenterology, infertility, obstetrics/gynecology, orthopedics and urology. For more information, call 1-888-FERRING (1-888-337-7464) or visit www.FerringUSA.com.

 


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Related medicine technology :

1. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
2. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
3. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
4. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
5. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
6. Isis Reports Financial Results and Highlights for First Quarter 2012
7. Delcath Highlights First Quarter 2012 And Recent Accomplishments
8. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
9. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
10. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
11. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... 31, 2020 , ... Welltech1, the first Israeli VC fund ... $400,000 in PopBase, one of two start-ups that beat 152 companies in the ... , The competition was part of the GWI’s The Wellness Moonshot: A ...
(Date:8/31/2020)... ... , ... Cloudticity announced today that Network Products Guide, industry’s ... the 15th Annual 2020 Network PG’s IT World Awards®. , The IT World ... Guide honoring achievements of world’s best in organizational performance, product and service innovations, ...
(Date:8/28/2020)... ... August 28, 2020 , ... Dr. Raheleh Sarbaziha ... unique perspective and approach. Armed with her qualifications from Ross University School of ... knowledge of the human body with the nation and world. With a fellowship ...
Breaking Medicine Technology:
(Date:9/1/2020)... NAPLES, Fla. (PRWEB) , ... September 01, 2020 ... ... and Reconstructive Surgeon with specialty fellowship training in aesthetic surgery of the face, ... Gill, MD – the only female-owned premier boutique plastic surgery and aesthetic practice ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... donated 1,400 N95 face masks to medical first responders across the United States. ... make donations of personal protective equipment (PPE) medical centers , hospitals ...
(Date:8/31/2020)... ... 31, 2020 , ... Smile Brands Inc., one of the ... States, today announced the grand opening of another affiliated Bright Now! Dental ... convenient hours, a comfortable office, and full-service care at the new Beaumont location. ...
(Date:8/31/2020)... Calif. (PRWEB) , ... August 31, 2020 , ... ... leadership experience working, both directly with persons with autism and other developmental disabilities, ... expertise includes early intervention, parent education, adolescents with autism, school consultation, and staff ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , Hespiro™ is a ... respiratory conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It ... gas and scrubs it free of carbon dioxide in a completely closed “rebreather” ...
Breaking Medicine News(10 mins):